Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myr (MYRG) EBITDA (2016 - 2025)

Myr (MYRG) has disclosed EBITDA for 16 consecutive years, with $37.8 million as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA rose 297.3% to $37.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $122.9 million, a 471.77% increase, with the full-year FY2025 number at $122.9 million, up 471.77% from a year prior.
  • EBITDA was $37.8 million for Q4 2025 at Myr, up from $30.3 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $37.8 million in Q4 2025 to a low of -$16.4 million in Q2 2024.
  • A 5-year average of $20.0 million and a median of $22.0 million in 2021 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: tumbled 167.38% in 2024, then soared 297.3% in 2025.
  • Myr's EBITDA stood at $20.8 million in 2021, then increased by 24.59% to $25.9 million in 2022, then increased by 3.58% to $26.8 million in 2023, then tumbled by 64.48% to $9.5 million in 2024, then skyrocketed by 297.3% to $37.8 million in 2025.
  • Per Business Quant, the three most recent readings for MYRG's EBITDA are $37.8 million (Q4 2025), $30.3 million (Q3 2025), and $31.3 million (Q2 2025).